FDA Hired An Independent Contractor To Analyze Plan B Comments, Von Eschenbach Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Acting Commissioner ducks questions from Rep. Sam Farr (D-Calif.) on a timeline for Plan B's OTC switch.
You may also be interested in...
Temp To Perm? Von Eschenbach Slated To Be Nominated As FDA Commissioner
The Bush Administration appears to be preparing to nominate FDA Acting Commissioner von Eschenbach as permanent agency head.
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement